{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:17:07Z","timestamp":1789427827875,"version":"build-2803163510"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Genitourinary syndrome of menopause (GSM) is a widespread condition with a great impact on quality of life and self-image.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>We aimed to systematically review the current literature on CO2-Laser therapy efficacy for the treatment of GSM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>MEDLINE and Embase databases were systematically queried in December 2020 Studies included women with a diagnosis of Vulvo-Vaginal Atrophy (VVA) or GSM without an history of gynaecological and\/or breast cancer, pelvic organ prolapse staged higher than 2, pelvic radiotherapy or Sjogren\u2019s Syndrome. The quality of the evidence was assessed with the Cochrane risk of bias tool. This study is registered on PROSPERO, number CRD42021238121.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>Effects of CO2-Laser therapy on GSM symptoms assessed through subjective or objective efficacy measurement methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 803 articles were identified. Of these, 25 studies were included in this review for a total of 1,152 patients. All studies showed a significant reduction in VVA and\/or GSM symptoms (dryness, dyspareunia, itching, burning, dysuria). The pooled mean differences for the symptoms were: dryness -5.15 (95% CI:-5.72,-4.58; P &amp;lt; .001; I2:62%; n = 296), dyspareunia -5.27 (95% CI:-5.93,-4.62; P &amp;lt; .001; I2:68%; n = 296), itching -2.75 (95% CI:-4.0,-1.51; P &amp;lt; .001; I2:93%; n = 281), burning -2.66 (95% CI:-3.75, -1.57; P &amp;lt; .001; I2:86%; n = 296) and dysuria -2.14 (95% CI:-3.41,-0.87; P &amp;lt; .001; I2:95%; n = 281). FSFI, WHIS and VMV scores also improved significantly. The pooled mean differences for these scores were: FSFI 10.8 (95% CI:8.41,13.37; P &amp;lt; .001; I2:84%; n = 273), WHIS 8.29 (95% CI:6.16,10.42; P &amp;lt; .001; I2:95%; n = 262) and VMV 30.4 (95% CI:22.38,38.55; P &amp;lt; .001; I2:24%; n = 68). CO2-Laser application showed a beneficial safety profile and no major adverse events were reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Implications<\/jats:title>\n                    <jats:p>Vaginal laser treatment resulted in both a statistically and clinically significant improvement in GSM symptoms. FSFI improved significantly in all 8 included studies but it reached a clinically relevant level only in 2 of them.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Strengths &amp; Limitations<\/jats:title>\n                    <jats:p>The strength of the current meta-analysis is the comprehensive literature search. We reported data from a high number of patients (1,152) and high number of laser applications (more than 3,800). The main limitations are related to the high heterogeneity of the included studies investigating laser effects. Moreover, most of them are single center and nonrandomized studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The data suggest that CO2-Laser is a safe energy-based therapeutic option for the management of VVA and\/or GSM symptoms in postmenopausal women; however, the quality of the body of evidence is \u201cvery low\u201d or \u201clow\u201d.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.jsxm.2021.12.010","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T21:58:29Z","timestamp":1643407109000},"page":"452-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis"],"prefix":"10.1093","volume":"19","author":[{"given":"Maurizio","family":"Filippini","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hospital State of Republic of San Marino , San Marino , Republic of San Marino"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Porcari","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro F.","family":"Ruffolo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, IRCCS San Raffaele Scientific Institute, University Vita and Salute , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Casiraghi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, IRCCS San Raffaele Scientific Institute, University Vita and Salute , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Farinelli","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hospital State of Republic of San Marino , San Marino , Republic of San Marino"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Uccella","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Franchi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Candiani","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, IRCCS San Raffaele Scientific Institute, University Vita and Salute , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Salvatore","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, IRCCS San Raffaele Scientific Institute, University Vita and Salute , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"2023010614052515000_bib0001","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s Sexual Health and the North American Menopause Society","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause"},{"key":"2023010614052515000_bib0002","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/GME.0000000000001260","article-title":"EVES Study investigators. The burden of vulvovaginal atrophy on women\u2019s daily living: implications on quality of life from a face-to-face real-life survey","volume":"26","author":"Nappi","year":"2019","journal-title":"Menopause"},{"key":"2023010614052515000_bib0003","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.maturitas.2013.05.003","article-title":"The CLOSER survey: impact of postmenopausal vaginal discomfort on relationships between women and their partners in Northern and Southern Europe","volume":"75","author":"Nappi","year":"2013","journal-title":"Maturitas"},{"key":"2023010614052515000_bib0004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4065\/mcp.2009.0413","article-title":"Vulvovaginal atrophy","volume":"85","author":"Mac Bride","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"2023010614052515000_bib0005","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/GME.0000000000001609","article-title":"The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society","volume":"27","author":"The North American Menopause Society (NAMS)","year":"2020","journal-title":"Menopause."},{"key":"2023010614052515000_bib0006","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jsxm.2017.01.010","article-title":"The Women\u2019s EMPOWER Survey: Identifying Women\u2019s Perceptions on Vulvar and Vaginal Atrophy and Its Treatment","volume":"14","author":"Kingsberg","year":"2017","journal-title":"J Sex Med"},{"key":"2023010614052515000_bib0007","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.maturitas.2020.09.011","article-title":"Knowledge of genito-urinary syndrome of menopause among Italian gynecologists: the DIADEM survey","volume":"143","author":"Alvisi","year":"2021","journal-title":"Maturitas"},{"key":"2023010614052515000_bib0008","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697137.2015.1129166","article-title":"IMS Writing Group. 2016 IMS Recommendations on women\u2019s midlife health and menopause hormone therapy","volume":"19","author":"Baber","year":"2016","journal-title":"Climacteric"},{"key":"2023010614052515000_bib0009","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/GME.0000000000001138","article-title":"The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women\u2019s Sexual Health (ISSWSH) expert consensus panel review","volume":"25","author":"Simon","year":"2018","journal-title":"Menopause"},{"key":"2023010614052515000_bib0010","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/GME.0000000000000401","article-title":"Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study","volume":"22","author":"Salvatore","year":"2015","journal-title":"Menopause"},{"key":"2023010614052515000_bib0011","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10103-014-1677-2","article-title":"Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment","volume":"30","author":"Zerbinati","year":"2015","journal-title":"Lasers Med Sci"},{"key":"2023010614052515000_bib0012","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ijgo.13561","article-title":"Physical methods for the treatment of genitourinary syndrome of menopause: A systematic review","volume":"153","author":"Sarmento","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"2023010614052515000_bib0013","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.maturitas.2015.08.001","article-title":"Genitourinary syndrome of menopause and the use of laser therapy","volume":"82","author":"Hutchinson-Colas","year":"2015","journal-title":"Maturitas"},{"key":"2023010614052515000_bib0014","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11934-018-0831-y","article-title":"Laser Therapy for Genitourinary Syndrome of Menopause","volume":"19","author":"Rabley","year":"2018","journal-title":"Curr Urol Rep"},{"key":"2023010614052515000_bib0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.maturitas.2017.06.029","article-title":"Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis","volume":"103","author":"Pitsouni","year":"2017","journal-title":"Maturitas"},{"key":"2023010614052515000_bib0016","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/GCO.0000000000000230","article-title":"The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy","volume":"27","author":"Salvatore","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2023010614052515000_bib0017","first-page":"127","article-title":"Non-invasive treatment of vulvovaginal atrophy in menopause with CO2 laser","volume":"73","author":"D\u2019oria","year":"2020","journal-title":"Minerva Ginecol"},{"key":"2023010614052515000_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2023010614052515000_bib0019","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2023010614052515000_bib0020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"2023010614052515000_bib0021","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"2023010614052515000_bib0022","first-page":"1","article-title":"Validation of the Thai Version of ICIQ-VS (International Consultation on Incontinence Questionnaire -Vaginal symptoms) in Thai Women","volume":"39","author":"Sriwat","year":"2016","journal-title":"Ramathibodi Medical Journal"},{"key":"2023010614052515000_bib0023","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2023010614052515000_bib0024","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2023010614052515000_bib0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2023010614052515000_bib0026","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/GME.0000000000000955","article-title":"Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women","volume":"25","author":"Cruz","year":"2018","journal-title":"Menopause"},{"key":"2023010614052515000_bib0027","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/GME.0000000000001416","article-title":"A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial","volume":"27","author":"Paraiso","year":"2020","journal-title":"Menopause"},{"key":"2023010614052515000_bib0028","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/GME.0000000000001333","article-title":"Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial","volume":"26","author":"Politano","year":"2019","journal-title":"Menopause"},{"key":"2023010614052515000_bib0029","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/GME.0000000000001542","article-title":"Treatment for vaginal atrophy using microablative fractional CO2 laser: a randomized double-blinded sham-controlled trial","volume":"27","author":"Ruanphoo","year":"2020","journal-title":"Menopause"},{"key":"2023010614052515000_bib0030","article-title":"CO2 laser and the genitourinary syndrome of menopause: a randomized sham-controlled trial. Climacteric [Internet]","volume-title":"Obstetrics and Gynecology Unit","author":"Salvatore","year":"2020"},{"key":"2023010614052515000_bib0031","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/GME.0000000000001206","article-title":"Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results","volume":"26","author":"Athanasiou","year":"2019","journal-title":"Menopause"},{"key":"2023010614052515000_bib0032","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s10103-017-2293-8","article-title":"Microablative fractional CO2 laser for the genitourinary syndrome of menopause: power of 30 or 40 W?","volume":"32","author":"Pitsouni","year":"2017","journal-title":"Lasers Med Sci"},{"key":"2023010614052515000_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2019.07.010","article-title":"The results of new low dose fractional CO2 Laser - A prospective clinical study in France","volume":"49","author":"Marin","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2023010614052515000_bib0034","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.maturitas.2016.09.012","article-title":"Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: An observational study","volume":"94","author":"Pitsouni","year":"2016","journal-title":"Maturitas"},{"key":"2023010614052515000_bib0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/lsm.23247","article-title":"Fractional Co2 Laser Treatment of the Vulva and Vagina and the Effect of Postmenopausal Duration on Efficacy","volume":"53","author":"Alexiades","year":"2020","journal-title":"Lasers Surg Med"},{"key":"2023010614052515000_bib0036","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.maturitas.2020.02.009","article-title":"Safety evaluation of fractional CO2 laser treatment in post-menopausal women with vaginal atrophy: A prospective observational study","volume":"135","author":"Di Donato","year":"2020","journal-title":"Maturitas"},{"key":"2023010614052515000_bib0037","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5978\/islsm.18-OR-04","article-title":"Early effect of fractional CO2 laser treatment in Post-menopausal women with vaginal atrophy","volume":"27","author":"Eder","year":"2018","journal-title":"Laser Ther"},{"key":"2023010614052515000_bib0038","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5978\/islsm.28_19-OR-06","article-title":"Long-Term Safety and Efficacy of Fractional CO2 Laser Treatment in Post-Menopausal Women with Vaginal Atrophy","volume":"28","author":"Eder","year":"2019","journal-title":"Laser Ther"},{"key":"2023010614052515000_bib0039","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.maturitas.2014.12.006","article-title":"Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser","volume":"80","author":"Perino","year":"2015","journal-title":"Maturitas"},{"key":"2023010614052515000_bib0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/13697137.2014.899347","article-title":"A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study","volume":"17","author":"Salvatore","year":"2014","journal-title":"Climacteric"},{"key":"2023010614052515000_bib0041","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/GME.0000000000000700","article-title":"An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy","volume":"23","author":"Sokol","year":"2016","journal-title":"Menopause"},{"key":"2023010614052515000_bib0042","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/GME.0000000000000839","article-title":"Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes","volume":"24","author":"Sokol","year":"2017","journal-title":"Menopause"},{"key":"2023010614052515000_bib0043","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/13697137.2014.975197","article-title":"Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy","volume":"18","author":"Salvatore","year":"2015","journal-title":"Climacteric"},{"key":"2023010614052515000_bib0044","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/13697137.2016.1212006","article-title":"The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women","volume":"19","author":"Athanasiou","year":"2016","journal-title":"Climacteric"},{"key":"2023010614052515000_bib0045","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.maturitas.2017.07.007","article-title":"CO2-laser for the genitourinary syndrome of menopause. How many laser sessions?","volume":"104","author":"Athanasiou","year":"2017","journal-title":"Maturitas"},{"key":"2023010614052515000_bib0046","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejogrb.2017.03.036","article-title":"Safety and long-term efficacy of fractional CO2 laser treatment in women suffering from genitourinary syndrome of menopause","volume":"213","author":"Behnia-Willison","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023010614052515000_bib0047","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/asj\/sjy087","article-title":"Treatment to External Labia and Vaginal Canal With CO2 Laser for Symptoms of Vulvovaginal Atrophy in Postmenopausal Women","volume":"39","author":"Samuels","year":"2019","journal-title":"Aesthet Surg J"},{"key":"2023010614052515000_bib0048","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/lsm.23066","article-title":"Efficacy of fractional CO2 laser in the treatment of genitourinary syndrome of menopause in Latin-American Population: First Peruvian experience","volume":"51","author":"Tovar-Huamani","year":"2019","journal-title":"Lasers Surg Med"},{"key":"2023010614052515000_bib0049","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1524-4741.2009.00766.x","article-title":"Quality of life after breast cancer: survivorship and sexuality","volume":"15","author":"Dizon","year":"2009","journal-title":"Breast J"},{"key":"2023010614052515000_bib0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","article-title":"Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen","volume":"28","author":"Dowsett","year":"2010","journal-title":"J Clin Oncol"},{"key":"2023010614052515000_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230681","article-title":"Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer","volume":"15","author":"Martino","year":"2020","journal-title":"PLoS One"},{"key":"2023010614052515000_bib0052","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00404-016-4118-6","article-title":"Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors","volume":"294","author":"Pieralli","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"2023010614052515000_bib0053","doi-asserted-by":"crossref","first-page":"e539","DOI":"10.1016\/j.clbc.2021.01.006","article-title":"Microablative Fractional CO2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-week Follow-up","volume":"21","author":"Salvatore","year":"2021","journal-title":"Clin Breast Cancer"},{"key":"2023010614052515000_bib0054","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"2023010614052515000_bib0055","volume-title":"FDA Warns Against Use of Energy-Based Devices to Perform Vaginal \u201cRejuvenation\u201d or Vaginal Cosmetic Procedures: FDA Safety Communication. FDA","author":"Health C for D and R","year":"2018"},{"key":"2023010614052515000_bib0056","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s10103-019-02744-1","article-title":"In response to the FDA warning about the use of photomedicine in gynecology","volume":"34","author":"Escribano","year":"2019","journal-title":"Lasers Med Sci"},{"key":"2023010614052515000_bib0057","author":"MonaLisa Touch\u00ae - DEKA"},{"key":"2023010614052515000_bib0058","author":"About Candela | Candela Medical"},{"key":"2023010614052515000_bib0059","volume-title":"Lumenis: Leading Medical Equipment & Innovative Laser Technologies"},{"key":"2023010614052515000_bib0060","author":"IDS"},{"key":"2023010614052515000_bib0061","author":"Aphrodite | BHlaser"},{"key":"2023010614052515000_bib0062","doi-asserted-by":"crossref","first-page":"65","DOI":"10.15171\/jlms.2020.11","article-title":"Effect of the Fractional CO2 Laser on the Quality of Life, General Health, and Genitourinary Symptoms in Postmenopausal Women With Vaginal Atrophy: A Prospective Cohort","volume":"11","author":"Adabi","year":"2020","journal-title":"J Lasers Med Sci"},{"key":"2023010614052515000_bib0063","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/gme.0b013e318182f84b","article-title":"Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach","volume":"15","author":"Ettinger","year":"2008","journal-title":"Menopause"},{"key":"2023010614052515000_bib0064","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5301\/je.5000184","article-title":"Microablative fractional CO2 laser improves dyspareunia related to vulvovaginal atrophy: A pilot study","volume":"6","author":"Salvatore","year":"2014","journal-title":"J of Endometriosis and Pelvic Pain Disorders"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609521008304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609521008304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/19\/3\/452\/48420348\/jsm_19_3_452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/19\/3\/452\/48420348\/jsm_19_3_452.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T09:50:08Z","timestamp":1675936208000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/19\/3\/452\/6961232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":64,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,1,28]]},"published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2021.12.010","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2022,1,28]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2021.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021, International Society of Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}